UCL Business

www.uclb.com
Profile Unclaimed

UCL Business Reviews

5 Reviews
3.5
5 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
(no image)
Cengiz Tarhan
1 Rating
  •  

    ucl

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Current Employee - Student in London, England (UK)
    Current Employee - Student in London, England (UK)

    I have been working at UCL Business full-time (more than 3 years)

    Pros

    this is a good education environment

    Cons

    i cannot find any cons

    Advice to ManagementAdvice

    good

UCL Business Interviews

Interview Experience

Interview Experience

66%
33%
0%

Getting an Interview

Getting an Interview

72%
27%

Interview Difficulty

3.7
Average

Interview Difficulty

Hard

Average

Easy
  1.  

    Research Associate Interview

    Anonymous Employee in UCLA, CA
    Anonymous Employee in UCLA, CA
    Application Details

    I applied online. The process took a weekinterviewed at UCL Business in March 2013.

    Interview Details

    why you are interested into this job?
    examples for team work
    examples for problem sovling
    career plan in 5 year's time

    Interview Questions
    No Offer
    Positive Experience
    Average Interview

UCL Business Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.uclb.com
Headquarters London, United Kingdom
Size 16 to 50 Employees
Founded Unknown
Type Company - Private
Industry Finance
Revenue $5 to $10 million (USD) per year

UCLBusiness's version of alchemy is transforming ideas into money. Commercializing biomedical and other scientific research from parent University College London is the mission at hand for the company, formerly UCL Biomedica, which was created out of predecessor firms UCL Ventures and Freemedic and the college's own knowledge transfer department. UCL Business helps provide funding for the university through an investment fund of about £1.5 million and through its involvement with such spin-off companies as Ark Therapeutics, Arrow Therapeutics, Biovex, Ionix... More

Work at UCL Business? Share Your Experiences

UCL Business

 
Click to Rate
or